Ipsen has announced the presentation of new study data on Dysport (abobotulinumtoxinA) in stroke and other neurological ...

Learn Microsoft Copilot basics, free and paid differences, and prompt tips to draft Outlook replies faster and summarize ...

For startups, every resource matters. Between product development, fundraising, and acquiring customers, business ...

Interim data from the ongoing EPITOME trial1 showed that 45.7% of stroke survivors with paresis developed post-stroke spasticity within 1 year<1% of stroke survivors receive BoNT-A treatment for ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced ...

Complete list of Ipsen presentations at TOXINS 2026: ...

From there, listening sessions were held with community members, typically in groups of two to 20 people, across Nicollet ...

A deep learning algorithm called FaceAge could allow clinicians to improve their qualitative assessments, and possibly catch ...

A new sustainability analysis based on long-term data from the Sustainable Brand Index identifies Vattenfall as a leading example of how consumer trust in sustainability can be built and strengthened ...

Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...

Need to improve throughput, lower detection limits, or other GC challenges? Join us to explore cutting-edge solutions for EPA ...

Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...